TMC Acquisitions LLC dba Tailor Made Compounding
Has TMC Acquisitions LLC dba Tailor Made Compounding received an FDA warning letter about GLP-1 drugs?
No FDA warning letter to TMC Acquisitions LLC dba Tailor Made Compounding naming a GLP-1 drug appears in FDA’s posted letters as of Nov 15, 2026. The company is listed here because openFDA has 1 drug recall report for it naming semaglutide, the latest initiated Aug 15, 2023.
FDA records in this index name TMC Acquisitions LLC dba Tailor Made Compounding on Aug 15, 2023.
- Type named in FDA records
- Not stated
- FDA warning letters
- 0
- Drug recall reports
- 1
- Drugs named
- Semaglutide
- Latest record
- Aug 15, 2023
FDA warning letters
No FDA warning letters in this index.
Drug recalls
| Record | |||||
|---|---|---|---|---|---|
| Aug 15, 2023 | Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding. | Lack of Assurance of Sterility | Class II | Terminated | D-1105-2023 |
FDA compounding inspections and actions
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists one facility under this exact legal name. These entries cover all of the facility’s compounding, not only GLP-1 drugs.
TMC Acquisitions, LLC dba Tailor Made Compounding, LLC, Nicholasville, KY (503A)
2 listed actions, including 1 Form 483 and 1 warning letter (2020 to 2022).
| Document | |||
|---|---|---|---|
| Mar 14, 2022 | Form 483 | 483 Issued 03/14/2022 | FDA copy (archived) |
| Apr 1, 2020 | Warning letter | Warning Letter (04/01/2020) | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own.
Pharmacy pages with the same legal name, built from FDA’s 503B list and compounding inspections and actions page: Tailor Made Compounding (TMC Acquisitions, LLC), Nicholasville, KY.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
- openFDA drug recall enforcement reports
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA warning letters (fda.gov full-text search)
Records last pulled Nov 15, 2026. Every entry links to the original public record.